VIDOVIC; DAMIR

Patent Applications and Registrations

Patent applications and USPTO patent grants for VIDOVIC; DAMIR.The latest application filed is for "compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease".

Company Profile

0.7.9

VIDOVIC; DAMIR - BELLEVUE WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions Employing Alternative Reading Frame Polypeptides For The Treatment Of Cancer And Infectious Disease App 20150344543 - GRADDIS; THOMAS ; et al.	2015-12-03
Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease Grant 9,051,385 - Graddis , et al. June 9, 2	2015-06-09
HLA-DR specific antibodies, compositions and methods Grant 8,354,507 - McMahan , et al. January 15, 2	2013-01-15
Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease App 20100034842 - Graddis; Thomas ; et al.	2010-02-11
Compositions and methods for dendritic cell-based immunotherapy Grant 7,659,117 - Laus , et al. February 9, 2	2010-02-09
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease Grant 7,597,894 - Graddis , et al. October 6, 2	2009-10-06
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation App 20060292165 - Laus; Reiner ; et al.	2006-12-28
Compositions and methods for dendritic cell-based immunotherapy Grant 7,060,279 - Laus , et al. June 13, 2	2006-06-13
Compositions and methods for dendritic cell-based immunotherapy App 20050232932 - Laus, Reiner ; et al.	2005-10-20
HLA-DR specific antibodies, compositions and methods App 20050208048 - McMahan, Cathy ; et al.	2005-09-22
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease App 20050112134 - Graddis, Thomas ; et al.	2005-05-26
Compositions and methods for dendritic cell-based immunotherapy App 20020061310 - Laus, Reiner ; et al.	2002-05-23
Selective apoptosis of neoplastic cells by an HLA-DR specific monoconal antibody App 20010053360 - Vidovic, Damir ; et al.	2001-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.